Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5

J Am Coll Cardiol. 2021 Apr 13;77(14):1778-1798. doi: 10.1016/j.jacc.2021.02.026.

Abstract

Maternal morbidity and mortality continue to rise in the United States, with cardiovascular disease as the leading cause of maternal deaths. Congenital heart disease is now the most common cardiovascular condition encountered during pregnancy, and its prevalence will continue to grow. In tandem with these trends, maternal cardiovascular health is becoming increasingly complex. The identification of women at highest risk for cardiovascular complications is essential, and a team-based approach is recommended to optimize maternal and fetal outcomes. This document, the second of a 5-part series, will provide practical guidance from pre-conception through postpartum for cardiovascular conditions that are predominantly congenital or heritable in nature, including aortopathies, congenital heart disease, pulmonary hypertension, and valvular heart disease.

Keywords: aortopathy; cardio-obstetrics; congenital; pregnancy; pulmonary hypertension.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Cardiovascular Diseases* / classification
  • Cardiovascular Diseases* / congenital
  • Cardiovascular Diseases* / physiopathology
  • Cardiovascular Diseases* / therapy
  • Female
  • Humans
  • Peripartum Period
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications, Cardiovascular* / classification
  • Pregnancy Complications, Cardiovascular* / physiopathology
  • Pregnancy Complications, Cardiovascular* / therapy
  • Pregnancy, High-Risk
  • Risk Adjustment / methods*